ALTTO Trials Findings For Treating HER2+ Breast Cancer - Mayo Clinic

preview_player
Показать описание
Mayo Clinic's Dr. Edith Perez says ALTTO trial finds single agent trastuzumab works best for treating HER2+ breast cancer.
Рекомендации по теме